M&A in Generic Drug Development: IP Valuation, Patent Strategy, and Dealmaking Intelligence
Introduction: The Market Paradox That Drives Every Deal The global generic drug industry has spent the last decade locked in […]
Biopharma Intelligence Infrastructure: The Definitive Technical Guide to Raw Data Platforms, AI Architecture, and Competitive Signal Processing
1. What Biopharma Intelligence Actually Does (and What Most Firms Think It Does) 1.1 The Operational Definition Biopharmaceutical business intelligence
Europe’s €30B Biologics Patent Cliff: The Complete Biosimilar Strategy Guide for Generic Manufacturers, IP Teams, and Investors
1. Executive Summary Between now and 2032, an estimated 110 biological medicines in Europe will lose intellectual property protection, with
Post-ANDA Patent Strategy: The Complete Playbook for Generic Market Domination
Generic drug development past the ANDA filing date is where most companies either build durable competitive moats or bleed out
Post-ANDA Patent Strategy: The Complete Playbook for Generic Market Domination Read Post »
The Global Generic Drug Market: Trends, Opportunities, and Challenges
Introduction: Generic Drugs as the Core Economic Infrastructure of Global Healthcare Scale, Dominance, and the Savings Calculus Generic drugs now
The Global Generic Drug Market: Trends, Opportunities, and Challenges Read Post »
Generic Drug Compliance: The Definitive Playbook on IP Risk, Regulatory Enforcement, and Manufacturing Quality
1. Executive Summary and Scope Generic drugs fill 91% of all U.S. prescriptions and generated an estimated $2.44 trillion in
Generic Drug Cost Optimization: Cut Production Costs, Win Patent Races, and Dominate the Market
1. Why Cost Structure Is Your Only Durable Weapon The global generic drug market reached approximately $491 billion in 2024.
Generic Drug Market Strategy: The Complete Competitive Playbook
Section 1: The Affordability Paradox: Why the Generic Market Rewards Complexity, Not Cost The generic drug industry has an identity
Generic Drug Market Strategy: The Complete Competitive Playbook Read Post »
What to Look for in a CDMO Contract: What Pharma IP Teams, R&D Leads, and Institutional Investors Actually Need to Know
1. The CDMO Market: Size, Consolidation, and the IP Stakes That Changed Everything The global contract development and manufacturing organization
